Compositions and methods for inhibiting viral replication

Details Compositions and methods for inhibiting viral replication Compositions and methods for inhibiting viral replication

2007-12-19

2010-06-29

Vivlemore, Tracy (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S024500

Reexamination Certificate

active

07745418

ABSTRACT:
The present invention relates to a double-stranded ribonucleic acid (dsRNA) having a nucleotide sequence which is less that 30 nucleotides in length and which is substantially identical to at least a part of a 3′-untranslated region (3′-UTR) of a (+) strand RNA virus, such as HCV, as well as pharmaceutical compositions comprising the dsRNA, together with a pharmaceutically acceptable carrier. The pharmaceutical compositions are useful for treating infections and diseases caused by the replication or activity of the (+) strand RNA virus, as well as methods for inhibiting viral replication.

REFERENCES:
patent: 6423489 (2002-07-01), Anderson et al.
patent: 6486299 (2002-11-01), Shimkets
patent: 6506559 (2003-01-01), Fire et al.
patent: 2002/0086356 (2002-07-01), Tuschl et al.
patent: 2002/0114784 (2002-08-01), Li et al.
patent: 2002/0123034 (2002-09-01), Canaani et al.
patent: 2002/0132346 (2002-09-01), Cibelli
patent: 2002/0162126 (2002-10-01), Beach et al.
patent: 2002/0173478 (2002-11-01), Gewirtz
patent: 2003/0027783 (2003-02-01), Zernicka-Goetz et al.
patent: 2003/0108923 (2003-06-01), Tuschl et al.
patent: 2003/0125281 (2003-07-01), Lewis et al.
patent: 2003/0143732 (2003-07-01), Fosnaugh et al.
patent: 2003/0148341 (2003-08-01), Sin et al.
patent: 2003/0157030 (2003-08-01), Davis et al.
patent: 2003/0176671 (2003-09-01), Reed et al.
patent: 2003/0180756 (2003-09-01), Shi et al.
patent: 2003/0190635 (2003-10-01), McSwiggen
patent: 2003/0198627 (2003-10-01), Arts et al.
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 199 03 713 (1999-01-01), None
patent: 19956568 (1999-11-01), None
patent: 20023125 (2000-01-01), None
patent: 10100588 (2001-01-01), None
patent: 10163098 (2001-12-01), None
patent: 10100586 (2002-04-01), None
patent: 10230996 (2002-07-01), None
patent: 10230997 (2002-07-01), None
patent: 1214945 (2000-01-01), None
patent: WO 99/32619 (1999-07-01), None
patent: WO 99/53050 (1999-10-01), None
patent: WO 99/61631 (1999-12-01), None
patent: WO 00/01846 (2000-01-01), None
patent: WO 00/44895 (2000-08-01), None
patent: WO 00/44914 (2000-08-01), None
patent: WO 00/63364 (2000-10-01), None
patent: WO 00/68374 (2000-11-01), None
patent: WO 01/18197 (2001-03-01), None
patent: WO 01/29058 (2001-04-01), None
patent: WO 01/36646 (2001-05-01), None
patent: WO 01/42443 (2001-06-01), None
patent: WO 01/48183 (2001-07-01), None
patent: WO 01/68836 (2001-09-01), None
patent: WO 01/70949 (2001-09-01), None
patent: WO 01/75164 (2001-10-01), None
patent: WO 01/92513 (2001-12-01), None
patent: WO 02/16620 (2002-02-01), None
patent: WO 02/26780 (2002-04-01), None
patent: WO 02/44321 (2002-06-01), None
patent: WO 02/055692 (2002-07-01), None
patent: WO 02/055693 (2002-07-01), None
patent: WO 02/061034 (2002-08-01), None
patent: WO 02/068635 (2002-09-01), None
patent: WO 02/068637 (2002-09-01), None
patent: WO 03/006477 (2003-01-01), None
patent: WO 03/012052 (2003-02-01), None
patent: WO 03/012082 (2003-02-01), None
patent: WO 03/016572 (2003-02-01), None
patent: WO 03/033700 (2003-04-01), None
patent: WO 03/035082 (2003-05-01), None
patent: WO 03/035083 (2003-05-01), None
patent: WO 03/035868 (2003-05-01), None
patent: WO 03/035869 (2003-05-01), None
patent: WO 03/035870 (2003-05-01), None
patent: WO 03/035876 (2003-05-01), None
patent: WO 03/070283 (2003-08-01), None
patent: WO 03/070750 (2003-08-01), None
patent: WO 03/070969 (2003-08-01), None
patent: WO 03/070972 (2003-08-01), None
patent: WO 03/074654 (2003-09-01), None
patent: WO 03/080794 (2003-10-01), None
patent: WO 03/080807 (2003-10-01), None
Hamada et al.,Antisense and Nucleic Acid Drug Devel. 12:301-309 (2002).
Ito et al.,J. Virology72:8789-8796 (1998).
Jackson et al.,Nature Biotech. 21:635-637 (2003).
Jacque Jean-Marc et al., “Modulation of HIV-1 Replication by RNA Interference”Nature(England) 418(6869):435-438 (2002).
Strickland et al., “Antisense RNA Directed Against the 3′ Noncoding Region Prevents Dormant MRNA Activation in Mouse Ocytes”Science, American Assoc. Adv. Science(USA) 241:680-684 (1988).
Wang et al., “Specific Inhibition of Coxsackie Virus B3 Translation and Replication by Phosphorothioate Antisense Oligodeoxynucleotides”Antimicrobial Agents and Chemotherapy(USA) 24(4):1043-1052 (2001).
Holen, T. et at, (2002), “Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor”,Nucleic Acids Research, 30(8):1757-1766.
Ambros, V., (2001), “Dicing Up RNAs”,Science, 293:811-813.
Elbashir, S.M. et al., (2001), “Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells”,Nature, 411:494-498.
Gautschi, O. et al., (2001), “Activity of a Novel bc1-2/bc1-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic Origins”,Journal of the National Cancer Institute, 93(6):463-471.
Lipardi, C. et al., (2001), “RNAi as Random Degradative PCR: siRNA Primers Convert mRNA into dsRNAs that Are Degraded to Generate New siRNAs”,Cell, 107:297-307.
Sharp, P.A., (2001), “RNA interference—2001”,Genes&Development, 15:485-490.
Sijen, T. et al., (2001), “On the Role of RNA Amplification in dsRNA-Triggered Gene Silencing”,Cell, 107:465-476.
Bass, B.L., (2000), “Double-Stranded RNA as a Template for Gene Silencing”,Cell, 101:235-238.
Cobaleda, C. et al., (2000), “In vivo inhibition by a site-specific catalytic RNA subunit of Rnase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment”,Blood, 95(3):731-737.
Hammond, S.M. et al., (2000), “An RNA-directed nuclease mediates post-transcriptional gene silencing inDrosophilacells”,Nature, 404:293-296.
Yang, D. et al., (2000), “Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi inDrosophilaembryos”,Current Biology, 10:1191-1200.
Wianny, F. et al., (2000), “Specific interference with gene function by double-stranded RNA in early mouse development”,Nature Cell Biology, 2:70-75.
Zamore, P.D. et al., (2000), “RNAi: Double-Stranded RNA Directs the ATP-Dependent Cleavage of mRNA at 21 to 23 Nucleotide Intervals”,Cell, 101:25-33.
Fire, A., (1999), “RNA-triggered gene silencing”,TIG, 15(9):358-363.
Tuschl, T. et al., (1999), “Targeted mRNA degradation by double-stranded RNA in vitro”,Genes&Development, 13 :3191-3197.
Wild, K. et al., (1999), “The 2 Å structure of helix 6 of the human signal recognition particle RNA”,Structure, 7(11):1345-1352.
Montgomery, M.K. et at, (1998), “Double-stranded RNA as a mediator in sequence-specific genetic silencing and co-suppression”,TIG, 14(7):255-258.
Lowy, D.R. et al., (1993), “Function and Regulation of RAS”,Annu. Rev. Biochem., 62:851-891.
Downward, J. et al., (1990), “Identification of a nucleotide exchange-promoting activity for p21ras,Proc. Natl.-Acad. Sci. USA”, 87:5998-6002.
Gibbs, J.B. et al., (1988), “Purification of ras GTPase activating protein from bovine brain”,Proc. Natl. Acad. Sci. USA, 85:5026-5030.
International Search Report of International Application No. PCT/EP02/00151.
Caplen, N.J., (2002), “A new approach to the inhibition of gene expression”,TRENDS in Biotechnology, 20(2):49-51.
Caplen, N.J. et al., (2001), “Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems”,Proc. Natl. Acad. Sci. USA, 98(17):9742-9747.
Doench, J.G. et al., (2003), “siRNAs can function as miRNAs”,Genes&Development, 17:438-442.
Donzé, O. et al., (2002), “RNA interference in mammalian cells using siRNAs synthesized with T7 RNA Polymerase”,Nucleic Acids Research, 30(10):e46(4pages).
Elbashir, S.M. et al., (2001), “RNA interference is mediated by 21- and 22-nucleotide RNAs”,Genes&Development, 15:188-200.
Elbashir,

Affiliated with

Also associated with

Rating

Compositions and methods for inhibiting viral replication does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for inhibiting viral replication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibiting viral replication will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4250702